Breast carcinoma survival in Europe and the United States : A population-based study (pages 715–722)
Milena Sant, Claudia Allemani, Franco Berrino, Michel P. Coleman, Tiiu Aareleid, Gilles Chaplain, Jan Willem Coebergh, Marc Colonna, Paolo Crosignani, Arlette Danzon, Massimo Federico, Lorenzo Gafà, Pascale Grosclaude, Guy Hédelin, Josette Macè-Lesech, Carmen Martinez Garcia, Henrik Møller, Eugenio Paci, Nicole Raverdy, Brigitte Tretarre, Evelyn M. I. Williams and European Concerted Action on Survival and Care of Cancer Patients (EUROCARE) Working Group
Version of Record online: 29 DEC 2003 | DOI: 10.1002/cncr.20038
Breast carcinoma survival rates were higher in the U.S. than in Europe, both overall and for each stage of disease at diagnosis. The overall excess risk of death was significantly higher among European women than U.S. women (referent group). Stage, age, surgery, and the number of lymph nodes evaluated accounted for most of the excess risk. Transatlantic differences in 5-year survival rates for women diagnosed with breast carcinoma between 1990–1992 were mainly attributable to differences in stage of disease at diagnosis. Resources should be invested to achieve an earlier diagnosis of breast carcinoma in Europe, especially for elderly women.